86
Last reporting period 30 Jun, 2024
Updated 19 Sep, 2024
Last price
—
Market cap $B
0.139
Exchange
XHKG - Hong Kong Exchange
0.87 B
Last period CFO ,CNY
-36%
CFO has decreased in 5 years
What is CFO ?
Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.
See also China Medical
Company Analysis
867.HK valuation, rating, competitors, insights and company profile
Eyestock Rating
867.HK financial analysis by Eyestock methodology
Valuation
867.HK valuation using historical relative method
Statements
867.HK Income Statements, Balance Sheet and Cash Flow Statements
Dividends
867.HK dividend yield and annual dividend
Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.
China Medical`s CFO for the period ended 2024-06-30 is 0.87 B CNY
